Arrow Financial’s United Therapeutics UTHR Stock Holding History

Arrow Financial’s Portfolio UTHR Stock Details UTHR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-100	Closed	-$8K	–	330
2019 Q3	$8K	Hold	100	–	–	﹤0.01%	290
2019 Q2	$8K	Hold	100	–	–	﹤0.01%	302
2019 Q1	$12K	Hold	100	–	–	﹤0.01%	290
2018 Q4	$11K	Hold	100	–	–	﹤0.01%	300
2018 Q3	$13K	Hold	100	–	–	﹤0.01%	300
2018 Q2	$11K	Hold	100	–	–	﹤0.01%	292
2018 Q1	$11K	Hold	100	–	–	﹤0.01%	293
2017 Q4	$15K	Hold	100	–	–	﹤0.01%	268
2017 Q3	$12K	Hold	100	–	–	﹤0.01%	283
2017 Q2	$13K	Hold	100	–	–	﹤0.01%	279
2017 Q1	$14K	Hold	100	–	–	﹤0.01%	277
2016 Q4	$14K	Hold	100	–	–	﹤0.01%	275
2016 Q3	$12K	Hold	100	–	–	﹤0.01%	279
2016 Q2	$11K	Hold	100	–	–	﹤0.01%	285
2016 Q1	$11K	Hold	100	–	–	﹤0.01%	291
2015 Q4	$16K	Hold	100	–	–	﹤0.01%	270
2015 Q3	$13K	Hold	100	–	–	﹤0.01%	267
2015 Q2	$17K	Hold	100	–	–	﹤0.01%	255
2015 Q1	$17K	Hold	100	–	–	﹤0.01%	259
2014 Q4	$13K	Hold	100	–	–	﹤0.01%	273
2014 Q3	$13K	Hold	100	–	–	﹤0.01%	299
2014 Q2	$9K	Hold	100	–	–	﹤0.01%	292
2014 Q1	$9K	Hold	100	–	–	﹤0.01%	291
2013 Q4	$11K	Sell	100 -100	-50%	-$9.02K	﹤0.01%	260
2013 Q3	$16K	Hold	200	–	–	﹤0.01%	244
2013 Q2	$13K	Buy	+200	New	+$12.9K	﹤0.01%	245

Other funds holding UTHR

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

Arrow Financial's UTHR Position: Q4 2019 in Review

Arrow Financial sold out of United Therapeutics (UTHR) in Q4 2019, closing a stake of 100 shares — an estimated $8K sold.

Arrow Financial first reported a position in UTHR in Q2 2013 and held it in 26 quarters. The position peaked at $17K in Q2 2015. 320 funds tracked by Wall St. Rank hold UTHR as of Q4 2019.

Arrow Financial reported no remaining United Therapeutics position as of Q4 2019 after selling out during the quarter.
Arrow Financial sold 100 United Therapeutics shares in Q4 2019, an estimated $8K.
Arrow Financial first reported a position in United Therapeutics in Q2 2013 and held it in 26 quarters.
Arrow Financial's United Therapeutics position peaked at $17K in Q2 2015.
320 funds tracked by Wall St. Rank held United Therapeutics as of Q4 2019.

Based on Arrow Financial's 13F filing for Q4 2019, filed 10 Feb 2020.